Latest / The Diagnostics & Lab Testing Business Brief
The Diagnostics & Lab Testing Business Brief — Wednesday, November 4, 2026
The Diagnostics & Lab Testing Business Brief — Wednesday, November 4, 2026
The business behind the tests. Today's developments shaping the diagnostics industry.
Sapphiros and binx health combine to form Onvaro: the combination unites binx health's FDA-cleared, CLIA-waived binx io molecular point-of-care platform (more than 1,000 installed instruments) and national commercial network with Sapphiros' printed electronics, blood collection technology, manufacturing and pipeline, with new capital from funds managed by KKR, Hildred and EQT Life Sciences; Mike Karsonovich becomes CEO and Namal…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.